Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human (tested or 100% immunogen sequence identity)
Western blot (1:64000) & (0.01 µg/ml)
IHC - Paraffin
Specificity and Use
PLA2G1B antibody was raised against synthetic peptide NKAHKNLDTKKYCQS from the C-terminus of human PLA2G1B (NP_000919.1). Percent identity by BLAST analysis: Human, Gorilla (100%); Gibbon, Monkey (87%); Marmoset, Panda, Dog, Pig (80%).
LS-E26464 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C55295. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
PLA2G1B is a secreted member of the phospholipase A2 (PLA2) class of enzymes, which is produced by the pancreatic acinar cells. The encoded calcium-dependent enzyme catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to release arachidonic acid (AA) and lysophospholipids. AA is subsequently converted by downstream metabolic enzymes to several bioactive lipophilic compounds (eicosanoids), including prostaglandins (PGs) and leukotrienes (LTs).